Hostname: page-component-89b8bd64d-j4x9h Total loading time: 0 Render date: 2026-05-06T22:43:52.988Z Has data issue: false hasContentIssue false

A telephone-supported cardiovascular lifestyle programme (CLIP) for lipid reduction and weight loss in general practice patients: a randomised controlled pilot trial

Published online by Cambridge University Press:  04 March 2013

Keren Louise Stuart
Affiliation:
Discipline of General Practice, School of Population Health and Clinical Practice, The University of Adelaide, Adelaide, Australia
Belinda Wyld
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Animal, Food and Health Sciences, PO Box 10041, Adelaide, SA 5000, Australia
Kathryn Bastiaans
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Animal, Food and Health Sciences, PO Box 10041, Adelaide, SA 5000, Australia
Nigel Stocks
Affiliation:
Discipline of General Practice, School of Population Health and Clinical Practice, The University of Adelaide, Adelaide, Australia
Grant Brinkworth
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Animal, Food and Health Sciences, PO Box 10041, Adelaide, SA 5000, Australia
Phil Mohr
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Animal, Food and Health Sciences, PO Box 10041, Adelaide, SA 5000, Australia
Manny Noakes*
Affiliation:
Commonwealth Scientific and Industrial Research Organisation (CSIRO), Animal, Food and Health Sciences, PO Box 10041, Adelaide, SA 5000, Australia
*
*Corresponding author: Email manny.noakes@csiro.au
Rights & Permissions [Opens in a new window]

Abstract

Objective

To evaluate a primary prevention care model using telephone support delivered through an existing health call centre to general practitioner-referred patients at risk of developing CVD, using objective measures of CVD risk reduction and weight loss.

Design

Participants were randomised into two groups: (i) those receiving a telephone-supported comprehensive lifestyle intervention programme (CLIP: written structured diet and exercise advice, plus seven telephone sessions with the Heart Foundation Health Information Service); and (ii) those receiving usual care from their general practitioner (control: written general lifestyle advice). Fasting plasma lipids, blood pressure, weight, waist circumference and height were assessed on general practice premises by a practice nurse at Weeks 0 and 12.

Setting

Two general practices in Adelaide, South Australia.

Subjects

Forty-nine men and women aged 48·0 (sd 5·88) years identified by their general practitioner as being at future risk of CVD (BMI = 33·13 (sd 5·39) kg/m2; LDL cholesterol (LDL-C) = 2·66 (sd 0·92) mmol/l).

Results

CLIP participants demonstrated significantly greater reductions in LDL-C (estimated mean (EM) = 1·98 (se 0·17) mmol/l) and total cholesterol (EM = 3·61 (se 0·21) mmol/l) at Week 12 when compared with the control group (EM = 3·23 (se 0·18) mmol/l and EM = 4·77 (se 0·22) mmol/l, respectively). There were no significant treatment effects for systolic blood pressure (F(1,45) = 0·28, P = 0·60), diastolic blood pressure (F(1,43) = 0·52, P = 0·47), weight (F(1,42) = 3·63, P = 0·063) or waist circumference (F(1,43) = 0·32, P = 0·577).

Conclusions

In general practice patients, delivering CLIP through an existing telephone health service is effective in achieving reductions in LDL-C and total cholesterol. While CLIP may have potential for wider implementation to support primary prevention of CVD, longer-term cost-effectiveness data are warranted.

Information

Type
Interventions
Copyright
Copyright © The Authors 2013 
Figure 0

Fig. 1 Flow diagram for the study recruitment process and participant flow across treatment conditions and general practice (CLIP, telephone-supported comprehensive lifestyle intervention programme; usual GP care, usual care from the general practitioner)

Figure 1

Table 1 Results for LDL-C, total cholesterol, SBP, DBP, weight, waist circumference and TSRQ autonomous motivation, at Week 0 and Week 12, for CLIP and control groups